Upregulated expression of kappa light chain by Epstein–Barr virus encoded latent membrane protein 1 in nasopharyngeal carcinoma cells via NF-κB and AP-1 pathways
- 1 February 2007
- journal article
- Published by Elsevier in Cellular Signalling
- Vol. 19 (2) , 419-427
- https://doi.org/10.1016/j.cellsig.2006.07.012
Abstract
No abstract availableKeywords
This publication has 43 references indexed in Scilit:
- The global health burden of infection‐associated cancers in the year 2002International Journal of Cancer, 2006
- Epstein–Barr virus encoded latent membrane protein 1 modulates nuclear translocation of telomerase reverse transcriptase protein by activating nuclear factor-κB p65 in human nasopharyngeal carcinoma cellsThe International Journal of Biochemistry & Cell Biology, 2005
- NF-κB and the Immunoglobulin κ Gene EnhancerThe Journal of Experimental Medicine, 2004
- Heterodimer formation between c-Jun and Jun B proteins mediated by Epstein–Barr virus encoded latent membrane protein 1Cellular Signalling, 2004
- Epstein-Barr virus latent membrane protein 1 modulates epidermal growth factor receptor promoter activity in a nuclear factor kappa B-dependent mannerCellular Signalling, 2004
- Cells in G2/M phase increased in human nasopharyngeal carcinoma cell line by EBV-LMP1 through activation of NF-κB and AP-1Cell Research, 2003
- NF-κB at the crossroads of life and deathNature Immunology, 2002
- LMP1 structure and signal transductionSeminars in Cancer Biology, 2001
- Human Papillomavirus E6E7-Mediated Adenovirus Cell Killing: Selectivity of Mutant Adenovirus Replication in Organotypic Cultures of Human KeratinocytesJournal of Virology, 2001
- Novel Inhibitors of Cytokine-induced IκBα Phosphorylation and Endothelial Cell Adhesion Molecule Expression Show Anti-inflammatory Effects in VivoJournal of Biological Chemistry, 1997